To confirm these clonal observations, we also established single cell clonal expansions from the TM00099 PDX model, a TDP type 1 TNBC established from a post-treatment patient tumor and exhibiting partial methylation at the BRCA1 promoter when assessed in the bulk tumor (Fig. 3C). This evidence concerns the gene SGCG and neoplasm.